Responses
Clinical/translational cancer immunotherapy
Original research
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
Compose a Response to This Article
Other responses
No responses have been published for this article.
